Effect of a specific cyclooxygenase-gene polymorphism (A-842G/C50T) on the occurrence of peptic ulcer hemorrhage

Digestive Diseases and Sciences

Volumn 51, Issue 12, 2006, Pages 2348-2352

  Van Oijen, Martijn G H ^a   Laheij, Robert J F ^a   Koetsier, Marjolein ^a   De Kleine, Evelien ^a   Te Morsche, René H M ^a   Van Kerkhoven, Lieke A S ^a   Jansen, Jan B M J ^a   Drenth, Joost P H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cyclooxygenase 1; Genetics; Helicobacter pylori; Hemorrhage; Peptic ulcer disease

Indexed keywords

CYCLOOXYGENASE 1; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; CASE CONTROL STUDY; FEMALE; GENETICS; HETEROZYGOTE; HUMAN; MALE; MIDDLE AGED; PEPTIC ULCER BLEEDING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CYCLOOXYGENASE 1; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PEPTIC ULCER HEMORRHAGE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS;

EID: 33846991602     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-006-9475-8     Document Type: Article

References (15)

1. Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340:1888-1899
2. Garcia Rodriguez LA, Jick H (1994) Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343:769-772
3. McCarthy DM (1995) Mechanisms of mucosal injury and healing: the role of non-steroidal anti-inflammatory drugs. Scand J Gastroenterol Suppl 208:24-29
4. Morita I (2002) Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat 68-69:165-175
5. Bombardier C, Laine L, Reicin A, et al. (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343:1520-1528
6. Kraemer SA, Meade EA, DeWitt DL (1992) Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences. Arch Biochem Biophys 293:391-400
7. Halushka MK, Walker LP, Halushka PV (2003) Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin Pharmacol Ther 73:122-130
8. Ulrich CM, Bigler J, Sibert J, et al. (2002) Cyclooxygenase 1 (COX1) polymorphisms in African-American and Caucasian populations. Hum Mutat 20:409-410
9. Silverstein FE, Faich G, Goldstein JL et al. (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284:1247-1255
10. Langenbach R, Morham SG, Tiano HF, et al. (1995) Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acidinduced inflammation and indomethacin-induced gastric ulceration. Cell 83:483-492
11. Dinchuk JE, Car BD, Focht RJ, et al. (1995) Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378:406-409
12. Fries S, Grosser T, Price TS et al. (2006) Marked Interindividual Variability in the Response to Selective Inhibitors of Cyclooxygenase-2. Gastroenterology 130:55-64
13. Lu CL,Chang SS,Wang SS, Chang FY, Lee SD(2004) Silent peptic ulcer disease: frequency, factors leading to "silence," and implications regarding the pathogenesis of visceral symptoms. Gastrointest Endosc 60:34-38
14. Bernersen B, Johnsen R, Straume B, Burhol PG, Jenssen TG, Stakkevold PA (1990) Towards a true prevalence of peptic ulcer: the Sorreisa gastrointestinal disorder study. Gut 31:989-992
15. Laine L,Maller ES,Yu C, Quan H, Simon T (2004) Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial. Gastroenterology 127:395-402